Heart Disease Clinical Trials in Dallas

Showing 421-438 of 438 trials

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease 007

NCT00595673

This trial is to compare PB127 echocardiography to other heart imaging studies.

Point Biomedical428 participantsStarted Jul 2002

Scottsdale, Arizona, United States • Scottsdale, Arizona, United States • San Francisco, California, United States +16 more locations

TERMINATED< 1 mile

Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function

NCT00568009

This is a randomized, double-blind, placebo-controlled, multi-center, sequential cohort study in subjects with congestive heart failure (CHF) and impaired renal function who are on stable furosemide treatment (³ 40 mg daily). A total of 50 subjects will be randomized to each increasing dose level of SLV320 or placebo in a sequential fashion.

Congestive Heart Failure

Solvay Pharmaceuticals300 participantsStarted Oct 2007

Whittier, California, United States • Largo, Florida, United States • Miami, Florida, United States +69 more locations

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease 007

Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function

Heart Disease Trials in Other Cities

Impact of Nesiritide Infusion for Decompensated Heart Failure in the Emergency Department

InSync Implantable Cardioverter Defibrillator Registry: Cardiac Resynchronization Therapy

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

Cardiovascular Outcomes in the VA's Rheumatoid Arthritis(VARA) Population

Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.

ARISE - Aggressive Reduction of Inflammation Stops Events

Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures

Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease

PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease

Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease

RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease

ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure

Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients

Dose Escalation Study of KW-3902 on Diuresis in Subjects With Congestive Heart Failure (CHF).

Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment

Other Conditions in Dallas